Richard J Stevens

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi request reprint Life-expectancy projection by modelling and computer simulation (UKPDS 46)
    R Stevens
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Woodstock Road, OX2 6HE, Oxford, UK
    Diabetes Res Clin Pract 50:S5-13. 2000
  2. ncbi request reprint The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
    R J Stevens
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    Clin Sci (Lond) 101:671-9. 2001
  3. ncbi request reprint UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes
    Richard J Stevens
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
    J Diabetes Complications 16:371-6. 2002
  4. doi request reprint Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study
    Elizabeth A Spencer
    Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Oxford, UK
    Eur J Epidemiol 23:793-9. 2008
  5. doi request reprint Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women
    Richard J Stevens
    Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford, United Kingdom
    Int J Cancer 124:2400-5. 2009
  6. ncbi request reprint Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66
    Richard J Stevens
    Diabetes Trials Unit and the Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U K
    Diabetes Care 27:201-7. 2004
  7. doi request reprint The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy
    Jennifer A Hirst
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Kidney Int 81:674-83. 2012
  8. ncbi request reprint Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes
    Ruth L Coleman
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Oxford, UK
    Diabetes Care 30:1292-3. 2007
  9. ncbi request reprint Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes
    Rury R Holman
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, UK
    Diabetes Care 28:1796-7. 2005
  10. ncbi request reprint UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
    Viti Kothari
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Oxford, United Kingdom
    Stroke 33:1776-81. 2002

Detail Information

Publications18

  1. ncbi request reprint Life-expectancy projection by modelling and computer simulation (UKPDS 46)
    R Stevens
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Woodstock Road, OX2 6HE, Oxford, UK
    Diabetes Res Clin Pract 50:S5-13. 2000
    ....
  2. ncbi request reprint The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
    R J Stevens
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    Clin Sci (Lond) 101:671-9. 2001
    ..001, except smoking for which P=0.0013) in likelihood ratio testing. This model provides the estimates of CHD risk required by current guidelines for the primary prevention of CHD in Type II diabetes...
  3. ncbi request reprint UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes
    Richard J Stevens
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
    J Diabetes Complications 16:371-6. 2002
    ..We conclude that duration of diabetes and HbA(1c) level better predict risk for photocoagulation when treated as two components of cumulative glucose exposure, than when treated as independent risk factors...
  4. doi request reprint Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study
    Elizabeth A Spencer
    Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Oxford, UK
    Eur J Epidemiol 23:793-9. 2008
    ..Of the modifiable factors examined in middle aged women with diabetes, smoking causes the greatest increase in cardiovascular disease, especially in those with insulin treated diabetes...
  5. doi request reprint Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women
    Richard J Stevens
    Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford, United Kingdom
    Int J Cancer 124:2400-5. 2009
    ..22-2.03, with vs. without such a history). These factors were also associated with increased mortality from pancreatic cancer. Height, alcohol consumption and physical activity showed little or no association with pancreatic cancer risk...
  6. ncbi request reprint Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66
    Richard J Stevens
    Diabetes Trials Unit and the Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U K
    Diabetes Care 27:201-7. 2004
    ..We investigated whether the risk of MI or stroke being fatal in type 2 diabetes can be estimated using information available around the time diabetes is diagnosed...
  7. doi request reprint The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy
    Jennifer A Hirst
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Kidney Int 81:674-83. 2012
    ..Treatment reduced urinary albumin excretion for Type 2 diabetic patients with and without microalbuminuria...
  8. ncbi request reprint Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes
    Ruth L Coleman
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Oxford, UK
    Diabetes Care 30:1292-3. 2007
  9. ncbi request reprint Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes
    Rury R Holman
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, UK
    Diabetes Care 28:1796-7. 2005
  10. ncbi request reprint UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
    Viti Kothari
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Oxford, United Kingdom
    Stroke 33:1776-81. 2002
    ..We developed mathematical models to estimate the risk of a first stroke using data from 4549 newly diagnosed type 2 diabetic patients enrolled in the UK Prospective Diabetes Study...
  11. ncbi request reprint Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)
    Amanda I Adler
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, and South Cleveland Hospital, Cleveland, United Kingdom
    Kidney Int 63:225-32. 2003
    ..This study sought to describe the development and progression through the stages of microalbuminuria, macroalbuminuria, persistently elevated plasma creatinine or renal replacement therapy (RRT), and death...
  12. ncbi request reprint UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes
    Amanda I Adler
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
    Diabetes Care 25:894-9. 2002
    ..To determine the role of hyperglycemia in prospective analyses of peripheral vascular disease (PVD) in type 2 diabetes, taking into account other potential risk factors...
  13. doi request reprint Statistical models for the control phase of clinical monitoring
    Richard J Stevens
    Department of Primary Health Care, University of Oxford, Oxford, UK
    Stat Methods Med Res 19:394-414. 2010
    ..We also present recalculations of results under alternative conditions, illustrating conceptual decisions about modelling the true or observed value of a clinical measure...
  14. pmc Reproductive history and pancreatic cancer incidence and mortality in a cohort of postmenopausal women
    Richard J Stevens
    Department of Primary Health Care, Oxford, OX3 7LF, UK
    Cancer Epidemiol Biomarkers Prev 18:1457-60. 2009
    ..Any effect of reproductive history and pancreatic cancer risk in women is likely to be weak, if it exists at all...
  15. pmc Pain over speed bumps in diagnosis of acute appendicitis: diagnostic accuracy study
    Helen F Ashdown
    Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK
    BMJ 345:e8012. 2012
    ..To assess the diagnostic accuracy of pain on travelling over speed bumps for the diagnosis of acute appendicitis...
  16. pmc Quantifying the effect of metformin treatment and dose on glycemic control
    Jennifer A Hirst
    Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
    Diabetes Care 35:446-54. 2012
    ..We reviewed the literature to quantify the effect of metformin treatment on glycated hemoglobin (HbA(1c)) levels in all types of diabetes and examine the impact of differing doses on glycemic control...
  17. ncbi request reprint Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry
    Xilin Yang
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, China
    Diabetes Care 30:65-70. 2007
    ..We sought to develop stroke risk equations for Chinese patients with type 2 diabetes in Hong Kong...
  18. ncbi request reprint Comparative study of prognostic value for coronary disease risk between the U.K. Prospective diabetes study and framingham models: response to Protopsaltis et al
    Richard J Stevens
    Diabetes Care 27:1843-4; author reply 1844-5. 2004